Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure.
Boudville N, Inderjeeth C, Elder GJ, Glendenning P. Boudville N, et al. Among authors: elder gj. Clin Endocrinol (Oxf). 2010 Sep;73(3):299-304. doi: 10.1111/j.1365-2265.2010.03821.x. Epub 2010 Apr 30. Clin Endocrinol (Oxf). 2010. PMID: 20507339
Effects of erythropoietin therapy on the lipid profile in end-stage renal failure.
Pollock CA, Wyndham R, Collett PV, Elder G, Field MJ, Kalowski S, Lawrence JR, Waugh DA, George CR. Pollock CA, et al. Kidney Int. 1994 Mar;45(3):897-902. doi: 10.1038/ki.1994.118. Kidney Int. 1994. PMID: 8196294
Pathophysiology and recent advances in the management of renal osteodystrophy.
Elder G. Elder G. J Bone Miner Res. 2002 Dec;17(12):2094-105. doi: 10.1359/jbmr.2002.17.12.2094. J Bone Miner Res. 2002. PMID: 12469904 Review.
25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease.
Elder GJ, Mackun K. Elder GJ, et al. J Bone Miner Res. 2006 Nov;21(11):1778-84. doi: 10.1359/jbmr.060803. J Bone Miner Res. 2006. PMID: 17002574
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC. Strippoli GF, et al. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006254. doi: 10.1002/14651858.CD006254. Cochrane Database Syst Rev. 2006. PMID: 17054287 Updated. Review.
Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5.
Elder GJ. Elder GJ. Nephrology (Carlton). 2007 Feb;12(1):90-4. doi: 10.1111/j.1440-1797.2006.00754.x. Nephrology (Carlton). 2007. PMID: 17295667
Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
Toussaint ND, Elder GJ, Kerr PG. Toussaint ND, et al. Among authors: elder gj. Clin J Am Soc Nephrol. 2009 Jan;4(1):221-33. doi: 10.2215/CJN.02550508. Epub 2008 Nov 5. Clin J Am Soc Nephrol. 2009. PMID: 18987295 Review.
Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.
Mainra R, Elder GJ. Mainra R, et al. Among authors: elder gj. Clin J Am Soc Nephrol. 2010 Jan;5(1):117-24. doi: 10.2215/CJN.03770609. Epub 2009 Dec 3. Clin J Am Soc Nephrol. 2010. PMID: 19965527 Free PMC article. Clinical Trial.
A rational guide to reducing fracture risk in dialysis patients.
Toussaint ND, Elder GJ, Kerr PG. Toussaint ND, et al. Among authors: elder gj. Semin Dial. 2010 Jan-Feb;23(1):43-54. doi: 10.1111/j.1525-139X.2009.00650.x. Semin Dial. 2010. PMID: 20331818 Review.
Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.
Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ. Hewitt NA, et al. Among authors: elder gj. Clin J Am Soc Nephrol. 2013 Jul;8(7):1143-9. doi: 10.2215/CJN.02840312. Epub 2013 Mar 14. Clin J Am Soc Nephrol. 2013. PMID: 23493381 Free PMC article. Clinical Trial.
78 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback